RBC Capital upgraded Bio-Techne (TECH) to Outperform from Sector Perform with a $73 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TECH:
- CoreWeave upgraded, Instacart downgraded: Wall Street’s top analyst calls
- Bio-Techne upgraded to Buy from Neutral at Citi
- Strategic Divestiture and Focus on Core Strengths Justify Buy Rating for Bio-Techne
- Bio-Techne’s Strong Q4 Performance and Strategic Moves Justify Buy Rating
- Bio-Techne Reports Solid Q4 2025 Results Amid Strategic Shift